Table 3.
Primary and secondary outcomes.
| All (n = 232) | SLED (n = 115) | CVVH (n = 117) | P | |
|---|---|---|---|---|
| Death from any cause by day 90 | 122 (52.6 %) | 57 (49.6 %) | 65 (55.6 %) | 0.434** |
| Death from any cause up to 30 August 2009 | 155 (66.8 %) | 76 (66.1 %) | 79 (67.5 %) | 0.926** |
| In-hospital mortality | 119 (51.3 %) | 57 (49.6 %) | 62 (53.0 %) | 0.696** |
| Mortality in ICU | 98 (42.2 %) | 49 (42.6 %) | 49 (41.9 %) | 0.984** |
| Mechanical ventilation | 205 (88.4%) | 101 (87.8%) | 104 (88.9%) | 0.962** |
| Days of mechanical ventilation | 1 9.4 ± 19.7 | 17.7 ± 19.4 | 20.9 ± 19.8 | 0.047* |
| Days in intensive care unit | 21.7 ± 21.1 | 19.6 ± 20.1 | 23.7 ± 21.9 | 0.038* |
| Recovery of kidney function in days after RRT initiation | 10.2 ± 14.5 | 10.0 ± 15.2 | 10.5 ± 14.0 | 0.049* |
| BP syst pre-treatment (mmHg) | 124.8 ± 14.0 | 125.1 ± 14.6 | 124.6 ± 13.5 | 0.434* |
| BP syst after treatment (mmHg) | 126.3 ± 16.4 | 128.3 ± 17.1 | 124.3 ± 15.6 | 0.051* |
| BP diast pre-treatment (mmHg) | 60.7 ± 10.3 | 60.7 ± 10.7 | 60.7 ± 10.0 | 0.420* |
| BP diast after treatment (mmHg) | 61.1 ± 10.7 | 61.8 ± 11.3 | 60.3 ± 10.2 | 0.250* |
| Hypotensive episodes | 1.6 ± 1.5 | 1.5 ± 1.4 | 1.8 ± 1.6 | 0.077* |
All values are expressed as number (percent) or mean ± SD; statistical analyses were performed for SLED versus CVVH. *One-tailed Wilcoxon test; **2 × 2 table Chi-Square test with Yates' correction. BP syst: systolic blood pressure; BP diast: diastolic blood pressure; SLED: sustained low efficiency dialysis; CVVH: continuous veno-venous hemofiltration.